The Mexico cardiovascular devices market was valued at USD 879.71 Million in 2025 and is expected to grow at a CAGR of 3.80%, reaching USD 1277.36 Million by 2035. The market growth is driven by increasing access to advanced healthcare infrastructure and rising awareness of heart-related conditions. Favorable government initiatives and the growing prevalence of cardiovascular diseases are driving demand. Innovation in minimally invasive procedures and growing investment in R&D are expected to boost market expansion during the forecast period.
Base Year
Historical Period
Forecast Period
According to Diego Samuel Claudio Moreno et al., 2025, in Mexico alone, over 200,000 deaths are attributed to cardiovascular diseases annually. This rising mortality burden is significantly driving the demand for cardiovascular devices.
In May 2024, COFEPRIS approved its first Software as a Medical Device (SaMD) for cardiac monitoring using FDA equivalency. Such regulatory advances are expected to accelerate innovation and drive growth in Mexico’s cardiovascular devices market.
Regulatory updates by COFEPRIS on low-risk devices are streamlining approvals, fostering faster product entry and innovation. This is accelerating Mexico’s cardiovascular devices market growth, supported by strong competition among key industry players.
Compound Annual Growth Rate
3.8%
Value in USD Million
2026-2035
*this image is indicative*
Cardiovascular devices are essential components of modern healthcare systems, offering advanced tools that support the prevention and management of heart-related conditions through enhanced clinical efficiency and patient care. In Mexico, the market is experiencing steady growth due to rising incidences of cardiovascular disorders, improving healthcare access, and increased government focus on chronic disease management. Technological innovation and a shift toward minimally invasive procedures are also fostering demand. The market is poised to grow at a CAGR of 3.80% during the forecast period of 2026–2035, underscoring the country's commitment to improving cardiovascular health outcomes.
Rising Cardiovascular Mortality to Enhance the Growth in the Market
The increasing prevalence of cardiovascular diseases is significantly accelerating the growth of the cardiovascular devices market in Mexico. As reported by the National Institute of Statistics and Geography, heart diseases emerged as the leading cause of death in the country in 2023, accounting for over 97,000 fatalities in Mexico. This alarming trend has heightened demand for advanced diagnostic and therapeutic cardiovascular devices. The urgency to address this public health concern is prompting both public and private healthcare sectors to invest in innovative technologies. This rising disease burden is expected to drive sustained market growth in the coming years.
The market is experiencing several key trends, including the increasing adoption of advanced TAVR systems and regulatory reforms aimed at improving accessibility.
Rising Adoption of Advanced TAVR Systems Is Likely to Boost Market Value
The market is experiencing a notable trend toward the increasing adoption of advanced transcatheter aortic valve replacement (TAVR) systems, driven by the need for minimally invasive cardiac care. In December 2024, SMT launched its Hydra TAVR system in Mexico, following approval by COFEPRIS. This reflects growing confidence in next-generation cardiovascular technologies tailored for improved patient outcomes and procedural safety. Such advancements are expected to significantly boost the market’s value and accelerate its overall growth trajectory.
Regulatory Reforms to Enhance the Accessibility of Mexico Cardiovascular Devices Market
An increasing emphasis on regulatory clarity is transforming the landscape of Mexico’s cardiovascular devices market. In July 2025, COFEPRIS implemented its first major update in over a decade to the classification and regulation of low-risk medical devices. The revised framework introduces structured annexes, faster review timelines, and reduced regulatory burdens for low-risk products such as certain cardiovascular tools. This streamlined approach is expected to attract more manufacturers, improve product availability, and significantly support the market’s continued growth and expansion.
Coronary Artery Disease to Lead the Segmentation Based on Application
The market encompasses a diverse range of applications, including coronary artery disease (CAD), heart failure, and others. This segmentation reflects the complex landscape of cardiovascular conditions requiring medical intervention. Among these, coronary artery disease is anticipated to lead the market, driven by its significantly high prevalence. According to Diego Samuel Claudio Moreno et al., 2025, over 200,000 cardiovascular-related deaths occurred in Mexico in 2022, with 76.5% linked to CAD and its complications, underscoring the critical need for advanced CAD-specific devices and treatments.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Boston Scientific is a global leader in medical innovation, offering a comprehensive range of cardiovascular devices in Mexico. Their portfolio includes pacemakers, defibrillators, and coronary stents, designed to address various heart conditions. The company's commitment to advancing cardiac care is evident in their continuous research and development efforts. In Mexico, Boston Scientific collaborates with healthcare professionals to provide cutting-edge solutions that improve patient outcomes. Their devices are known for reliability and technological advancements, making them a preferred choice among clinicians and patients alike. Boston Scientific's presence in Mexico underscores their dedication to enhancing cardiovascular health.
Abbott is a prominent player in the Mexico cardiovascular devices market, offering innovative solutions for heart disease management. Their product range includes diagnostic tools, stents, and heart failure management devices. Abbott's commitment to improving patient care is reflected in their advanced technologies and user-friendly designs. In Mexico, the company works closely with medical professionals to ensure their products meet local healthcare needs and regulatory standards. Abbott's focus on research and development drives continuous improvement in cardiovascular care, aiming to provide effective treatments that enhance patients' quality of life.
Medtronic is a leading medical technology company with a strong presence in Mexico’s cardiovascular devices market. Their extensive portfolio includes pacemakers, defibrillators, and coronary intervention products. Medtronic's innovations are designed to address a wide range of heart conditions, offering solutions that improve patient outcomes. In Mexican, the company collaborates with healthcare providers to deliver high-quality care and advanced treatments. Medtronic's commitment to excellence is evident in their continuous efforts to enhance the effectiveness and safety of their cardiovascular devices, benefiting both clinicians and patients.
B. Braun SE is a global medical technology company that offers a variety of cardiovascular devices in the Mexican market. Their product line includes vascular access systems, infusion therapy solutions, and surgical instruments used in cardiovascular procedures. B. Braun's focus on quality and innovation ensures that their devices meet the high standards required in cardiac care. In Mexico, the company works closely with healthcare institutions to provide reliable and effective solutions that support cardiovascular treatments. B. Braun's dedication to patient safety and clinical efficiency makes them a trusted partner in the healthcare sector.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Cardinal Health, Terumo Corporation, Edwards Lifesciences Corporation, Siemens Healthcare Private Limited, BD, Koninklijke Philips N.V., and LivaNova PLC.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type
Market Breakup by Application
Market Breakup by End User
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Device Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share